AHA. Alexander Holmes

A. Alexander Holmes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


A. Alexander Holmes has a total of 75 co-authors. Here are the top co-authors by number of shared publications:

  • Jean-Nicolas Vauthey

    Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA

    3 shared publications
  • D. F. Scollan

    Whitaker Biomedical Engineering Institute, Department of Biomedical Engineering, and Center for Computational Medicine and Biology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

    2 shared publications
  • Eve Simoneau

    Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA

    2 shared publications
  • J. Zhang

    Whitaker Biomedical Engineering Institute, Department of Biomedical Engineering, and Center for Computational Medicine and Biology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

    2 shared publications
  • Jeffrey E. Lee

    Department of Surgical Oncology, Hepato-Pancreato-Biliary Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA

    2 shared publications
  • Jonathan H. Waters

    2 shared publications

Latest Publications

  • The quantra hemostasis analyzer compared to thromboelastography (TEG) in the surgical oncologic population: A prospective observational trial

    by Olakunle Idowu, Ifey Ifeanyi‐Pillette, Pascal Owusu‐Agyemang, Allen Holmes, Piotr Kwater, Timothy Jackson, Gabriel Mena, Javier Lasala, Jagtar Singh Heir

    Background: Management of coagulopathy during major oncologic surgery can be multifactorial and challenging. Viscoelastic assays (VEAs) can be useful in providing vital data about the mechanism of coagulopathy in these dynamic circumstances.Objectives: A prospective nonrandomized observational study with the aim of describing the coagulation parameters of patients undergoing major oncologic surgery using the Quantra® and TEG® 5000 systems. Our secondary objectives included the correlation between Quantra and TEG parameters, and the times to result for both technologies.Methods: This study included 74 adults undergoing oncologic surgery with an anticipated blood loss of more than 500 ml. For each subject, whole blood samples for each device were collected at multiple points perioperatively for comparison.Results: Correlation coefficients between Quantra and TEG parameters were 0.8 and above, indicating a very strong correlation (p < .001). Correlation coefficients between conventional laboratory tests and Quantra ranged from 0.74 to 0.83, indicating a moderate correlation (p < .001). The mean time to obtain results and total processing time was shorter for Quantra in comparison to TEG.Conclusions: Quantra parameters strongly correlated with TEG parameters; however, Quantra parameters were available in shorter amount of time as it is specifically designed as a closed point of care device.


  • A randomized controlled trial of postoperative thoracic epidural analgesia versus intravenous patient controlled analgesia after major HPB surgery

    by T. Aloia, B. Kim, Y.S. Chun Segraves, J. Cata, M. Truty, A. Holmes, J. Soliz, K. Popat, D. Kennamer, T. Rahlfs, et al.


  • Open Access

    Middle Hepatic Vein Roadmap for a Safe Laparoscopic Right Hepatectomy

    by Katharina Joechle, Eduardo A. Vega, Masayuki Okuno, Eve Simoneau, Satoshi Ogiso, Timothy E. Newhook, David L. Ramirez, A. Alex Holmes, Jose M. Soliz, Yun Shin Chun, et al.

    When performing a right hepatectomy, the middle hepatic vein (MHV) should guide the parenchymal transection. MHV hotspots for bleeding can be anticipated w


  • A Randomized Controlled Trial of Postoperative Thoracic Epidural Analgesia Versus Intravenous Patient-controlled Analgesia After Major Hepatopancreatobiliary Surgery

    by Thomas A. Aloia, Bradford J. Md Kim, Yun Shin Segraves-Chun, Juan P. Cata, Mark J. Truty, Qiuling MD Shi, Alexander Holmes, Jose M. Soliz, Keyuri U. Popat, Thomas F. Rahlfs, et al.

    Objectives: The primary objective of this randomized trial was to compare thoracic epidural analgesia (TEA) to intravenous patient-controlled analgesia (IV-PCA) for pain control over the first 48 hours after hepatopancreatobiliary (HPB) surgery. Secondary endpoints were patient-reported outcomes, total narcotic utilization, and complications. Background: Although adequate postoperative pain control is critical to patient and surgeon success, the optimal analgesia regimen in HPB surgery remains controversial. Methods: Using a 2.5:1 randomization strategy, 140 patients were randomized to TEA (N = 106) or intravenous patient-controlled analgesia (N = 34). Patient-reported pain was measured on a Likert scale (0–10) at standard time intervals. Cumulative pain area under the curve was determined using the trapezoidal method. Results: Between the study groups key demographic, comorbidity, clinical, and operative variables were equivalently distributed. The median area under the curve of the postoperative time 0- to 48-hour pain scores was lower in the TEA group (78.6 vs 105.2 pain-hours, P = 0.032) with a 35% reduction in patients experiencing ≥7/10 pain (43% vs 62%, P = 0.07). Patient-reported outcomes and total opiate use further supported the benefit of TEA on patient experience. Anesthesia-related events requiring change in analgesic therapy were comparable (12.2% vs 2.9%, respectively, P = 0.187). Grade 3 or higher surgical complications (6.6% vs 9.4%), median length of stay (6 days vs 6 days), readmission (1.9% vs 3.1%), and return to the operating room (0.9% vs 3.1%) were similar (all P > 0.05). There were no mortalities in either group. Conclusions: In major HPB surgery, TEA provides a superior patient experience through improved pain control and less narcotic use, without increased length of stay or complications.


  • A multi-institutional pilot survey of anesthesia practices during proton radiation therapy

    by Pascal Owusu-Agyemang, Shannon M. Popovich, Acsa M. Zavala, David R. Grosshans, Antoinette Van Meter, Uduak U. Williams, Allen A. Holmes, Radha Arunkumar, Elizabeth Rebello, Mary Frances McAleer, et al.


  • In Vitro Evaluation of a Novel System for Monitoring Surgical Hemoglobin Loss

    by Gerhardt Konig, Allen A. Holmes, Rosario Garcia, Julianne M. Mendoza, Mazyar Javidroozi, Siddarth Satish, Jonathan H. Waters

    Ed after facial recognition technology. The aim of the study was to assess the accuracy and performance of the system on surgical laparotomy sponges in vitro. METHODS: Whole blood samples of premeasured hemoglobin (Hb) and volume were reconstituted from units of human packed red blood cells and plasma and distributed across surgical laparotomy sponges. Normal saline was added to simulate the presence of varying levels of hemodilution and/or irrigation use. Soaked sponges from 4 different manufacturers were scanned using the Triton System with Feature Extraction Technology (Gauss Surgical, Inc., Palo Alto, CA) under 3 different ambient light conditions in an operating room. Accuracy of Hb loss measurement was evaluated relative to the premeasured values using linear regression and Bland-Altman analysis. Correlations between studied variables and measurement bias were analyzed using nonparametric tests. RESULTS: The overall mean percent error for measure of Hb loss for the Triton System was 12.3% (95% confidence interval [CI], 8.2%−16.4%). A strong positive linear correlation between the premeasured and actual Hb masses was noted across the full range of intraoperative lighting conditions, including (A) high (r = 0.95 [95% CI, 0.93–0.96]), (B) medium (r = 0.94 [95% CI, 0.93–0.96]), and (C) low (r = 0.90 [95% CI, 0.87–0.93]) mean ambient light intensity. Bland-Altman analysis revealed a bias of 0.01 g [95% CI, −0.03 to 0.06 g] of Hb per sponge between the 2 measures. The corresponding lower and upper limits of agreement were −1.16 g (95% CI, −1.21 to −1.12 g) per sponge and 1.19 g (95% CI, 1.15–1.24 g) per sponge, respectively. Measurement bias of estimated blood loss and Hb mass using the new system were not associated with the volume of saline used to reconstitute the samples (P = 0.506 and P = 0.469, respectively), suggesting that the system is robust under a wide range of sponge saturation conditions. CONCLUSIONS: Mobile blood loss monitoring using the Triton system is accurate in assessing Hb mass on surgical sponges across a range of ambient light conditions, sponge saturation, saline contamination, and initial blood Hb. Utilization of this tool could significantly improve the accuracy of blood loss estimates....


  • Clinical Evaluation of a Novel System for Monitoring Surgical Hemoglobin Loss

    by Allen A. Holmes, Gerhardt Konig, Vicki Ting, Bridget Philip, Thomas Puzio, Siddarth Satish, Jonathan H. Waters

    Ogrammed with a unique algorithm modeled after facial recognition technology. In this study, we assessed the accuracy and performance of the system in surgical cases. METHODS: In this prospective, multicenter study, 46 patients undergoing surgery with anticipated significant blood loss contributed laparotomy sponges for hemoglobin (Hb) loss measurement using the Triton System with Feature Extraction Technology (Gauss Surgical, Inc., Los Altos, CA). The Hb loss measured by the new system was compared with that measured by manual rinsing of the sponges. Accuracy was evaluated using linear regression and Bland-Altman analysis. In addition, the new system’s calculation of blood volume loss was compared with the gravimetric method of estimating blood loss from intraoperative sponge weights. RESULTS: A significant positive linear correlation was noted between the new system’s measurements and the rinsed Hb mass (r = 0.93, P < 0.0001). Bland-Altman analysis revealed a bias of 9.0 g and narrow limits of agreement (−7.5 to 25.5 g) between the new system’s measures and the rinsed Hb mass. These limits were within the clinically relevant difference of ±30 g, which is approximately half of the Hb content of a unit of allogeneic whole blood. Bland-Altman analysis of the estimated blood loss on sponges using the gravimetric method demonstrated a bias of 466 mL (overestimation) with limits of agreement of −171 and 1103 mL, due to the presence of contaminants other than blood on the laparotomy sponges. CONCLUSIONS: The novel mobile monitoring system provides an accurate measurement of Hb mass on surgical sponges as compared with that of manual rinsing measurements and is significantly more accurate than the gravimetric method. Further study is warranted to assess the clinical use of the technology....


  • Awake Insertion of the Bonfils Retromolar Intubation Fiberscope™ in Five Patients with Anticipated Difficult Airways

    by Steven I. Abramson, Allen A. Holmes, Carin A. Hagberg

    Traditionally, an awake intubation is performed by flexible fiberoptic laryngoscopy. However, many new devices have been developed to assist anesthesiologists with both routine and difficult airway management, one of which is the Bonfils Retromolar Intubation Fiberscope™. This device may be more beneficial than the flexible fiberoptic laryngoscope since it can readily navigate through soft tissue and physically lift airway structures, is more affordable, durable, and easier to clean. This case series demonstrates successful use of the Bonfils Scope in five patients for awake orotracheal intubation with anticipated difficult airways.


  • Reconstruction of Cardiac Ventricular Geometry and Fiber Orientation Using Magnetic Resonance Imaging

    by D. F. Scollan, A. Holmes, J. Zhang, R. L. Winslow

    An imaging method for the rapid reconstruction of fiber orientation throughout the cardiac ventricles is described. In this method, gradient-recalled acqui